CASC2 and pulmonary arterial hypertension: Another study demonstrated that CASC2 attenuated hypoxia-induced proliferation and migration of HPASMCs through modulating the miR-222/ inhibitor of growth 5 (ING5) signaling axis [63], suggesting that targeting CASC2 could be effective to suppress vascular remodeling in PAH.